Attached files
| file | filename |
|---|---|
| 10-Q - ZIOPHARM ONCOLOGY INC | v165392_10q.htm |
| EX-31.1 - ZIOPHARM ONCOLOGY INC | v165392_ex31-1.htm |
| EX-31.2 - ZIOPHARM ONCOLOGY INC | v165392_ex31-2.htm |
EXHIBIT
32.1
CERTIFICATION
In
connection with the Quarterly Report on Form 10-Q of ZIOPHARM Oncology, Inc.
(the “Company”) for the period ended March 31, 2009 as filed with the Securities
and Exchange Commission on the date hereof (the “Report), we Jonathan Lewis, the
Principal Executive Officer of the Company and Richard E. Bagley, the Principal
Financial and Accounting Officer of the Company, hereby certify, pursuant to 18
U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, to our knowledge that:
|
(1)
|
the
Report fully complies with the requirements of Section 13(a) or 15(d), as
applicable, of the Securities Exchange Act of 1934, as amended,
and
|
|
(2)
|
the
information in the Report fairly presents, in all material respects, the
financial condition and results of operations of the
Company.
|
Dated:
November 10, 2009
|
/s/ Jonathan Lewis
|
|
Jonathan
Lewis, M.D., Ph.D.
Chief
Executive Officer
|
|
(Principal
Executive Officer)
|
Dated:
November 10, 2009
|
/s/ Richard E. Bagley
|
|
Richard
E. Bagley
President
and Chief Financial Officer
|
|
(Principal
Financial and Accounting
Officer)
|